CONSTITUTIONAL AND ANATOMICAL FEATURES OF ELDERLY MEN WITH SARCOPENIA

The prevalence of sarcopenia varies widely depending on the population of the surveyed population, differences in sex, age, ethnicity, living conditions, hospitalization, nursing home living, and assessment tools and methods. It is of interest to estimate the prevalence of sarcopenia in different populations of the elderly. The purpose of the study is to study the frequency of occurrence of sarcopenia in elderly men, depending on the somatotype and anthropometric features in order to determine the algorithm for its rapid diagnosis. A comprehensive anatomical and anthropological examination of 198 men aged 61 to 75 years, suffering from sarcopenia, was carried out. The results obtained were compared with those of 37 elderly men who do not have sarcopenia. The constitutional types of all participants in the study were identified according to the Rees–Eisenck method, the Shevkunenko-Geselevich classification, and body types according to Chernorutsky. The most common comorbidities associated with sarcopenia have been identified and analyzed. The constitutional types most predisposed to the manifestation of sarcopenia were identified. It is proved that on all used classifications the normosthenic according to Chernorutsky and Rees-Eisenck and mesomorphic according to Shevkunenko-Geselevich types prevailed. The most accessible method of somatotyping based on express diagnostics has been tested. It has been proven that hypersthenics are more often prone to sarcopenia, in contrast to representatives of other constitutional types according to Chernorutsky's classification. It was revealed that patients with type II diabetes mellitus (26,3%), with hypertension of I–II degree, chronic heart failure of functional class I (30,8%), obesity of I–II degree (22,7%), osteoporosis (15,1%) in history. The determination of the somatic constitution and the presence in the anamnesis of the most common comorbid conditions with sarcopenia that occur in elderly men helps to identify a predisposition to the development of sarcopenia, which in turn makes it possible to expressly diagnose patients for timely correction of the pathology aimed at eliminating and/or reduce the manifestations of the disease.

1. Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JW. Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas. 2015;82(4):418-423. DOI: 10.1016/j.maturitas.2015.08.006

2. Kara M, Kaymak B, Frontera W et al. Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM. Journal of rehabilitation medicine. 2021;53(6):jrm00209. DOI: 10.2340/16501977-2851

3. Papadopoulou SK. Sarcopenia: A Contemporary Health Problem among Older Adult Populations. Nutrients. 2020;12(5):1293. DOI: 10.3390/nu12051293.

4. Supriya R, Singh KP, Gao Y, et al. A Multifactorial Approach for Sarcopenia Assessment: A Literature Re-view. Biology. 2021;10(12):1354. DOI: 10.3390/biology10121354

5. Cruz-Jentoft AJ, Landi F, Schneider SM et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age and age-ing. 2014;43(6):748-759. DOI: 10.1093/ageing/afu115

6. Chen LK, Woo J, Assantachai P et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarco-penia Diagnosis and Treatment. Journal of the American Medical Directors Association. 2020;21(3):300-307.e2. DOI: 10.1016/j.jamda.2019.12.012

7. Bhasin S, Travison TG, Manini TM et al. Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium. Journal of the American Geriatrics Society. 2020;68(7):1410-1418. DOI: 10.1111/jgs.16372

8. Cruz-Jentoft AJ, Bahat G, Bauer J et al. Writing Group for the European Working Group on Sarcopenia in Old-er People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. DOI: 10.1093/ageing/afy169

9. Pleshchev IE, Achkasov EE, Nikolenko VN, Shkrebko AN. Sarkopenija: sovremennye podhody k diagnostike i reabilitacii. Sovremennye problemy nauki i obrazovanija. 2022;1: 66. In Russian DOI: 10.17513/spno.31443

10. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. Journal of cachexia, sarco-penia and muscle. 2016;7(5):512-514. DOI: 10.1002/jcsm.12147

11. Matveev SV, Uspenskiy AK, Uspenskaya YuK, Didur MD. Antropometricheskie kriterii, somatotip i funktsional'naya podgotovlennost' basketbolistov na razlichnykh etapakh sportivnoy podgotovki. Sportivnaya med-itsina: nauka i praktika. 2020;10(1):5-12. In Russian. DOI: 10.17238/ISSN2223-2524.2020.1.5

12. Kukes VG, Nikolenko VN, Pavlov CS, Zharikova TS et al. The correlation of somatotype of person with the de-velopment and course of various diseases: results of Russian research. Russian Open Medical Journal. 2018;7:e0301. DOI: 10.15275/rusomj.2018.0301

13. Romanenko AA. Ispol'zovanie indeksa W.L. Rees – N.J. Eysenck v otsenke fizicheskogo statusa muzhchin yunosheskogo vozrasta. Fundamental'nye issledovaniya. 2015;1(8):1671-1675. In Russian

14. Nikolenko VN, Nikitjuk DB, Klochkova SV. Somaticheskaja konstitucija i klinicheskaja medicina. Moskva: Prakticheskaja medicina, 2017.- 256s. In Russian

15. Tutel'yan VA, Razumov AN, Rozhkova EA i dr. Konstitutsional'no-anatomicheskie osobennosti i fizicheskiy status v starshikh vozrastnykh gruppakh v usloviyakh otnositel'noy normy. Zhurnal anatomii i gistopatologii. 2016;5(2):9-14. In Russian. DOI: 10.18499/2225-7357-2016-5-2-9-14

16. American Diabetes Association. 12. Older Adults: Standards of Medical Care in Diabetes-2019. Diabetes care. 2019; 42(1):139–147. DOI: 10.2337/dc19-S012

17. Liccini A, Malmstrom TK. Frailty and Sarcopenia as Predictors of Adverse Health Outcomes in Persons With Diabetes Mellitus. Journal of the American Medical Directors Association. 2016;17(9):846–851. DOI: 10.1016/j.jamda.2016.07.007

18. Izzo A, Massimino E, Riccardi G, Della Pepa G. A Narrative Review on Sarcopenia in Type 2 Diabetes Melli-tus: Prevalence and Associated Factors. Nutrients. 2021;13(1):183. DOI: 10.3390/nu13010183

19. Polyzos SA, Margioris AN. Sarcopenic obesity. Hormones (Athens, Greece). 2018;17(3):321–331. DOI: 10.1007/s42000-018-0049-x

20. He N, Zhang Y, Zhang L et al. Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview. Frontiers in Cardiovascular Medicine. 2021;8:743710. DOI: 10.3389/fcvm.2021.743710